Durvalumab and bevacizumab plus transarterial chemoembolization in unresectable hepatocellular carcinoma: a new paradigm?

Translational Gastroenterology and Hepatology 2026 Open access

Read full text
Authors: Maen Abdelrahim, Abdullah Esmail, Bandar Al-Judaibi
DOI: 10.21037/tgh-25-34
Cited by: 3

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cholangiocarcinoma and Gallbladder Cancer Studies Hepatitis B Virus Studies

Publication details

Journal / source
Translational Gastroenterology and Hepatology
Publisher
AME Publishing Company
Volume
11
Pages
1–1
Publication date
1 January 2026
Language
EN